Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
Alexander Stratigos(Andreas Sygros Hospital), Aleksandar Sekulić(Mayo Clinic Hospital), Ketty Peris(Università Cattolica del Sacro Cuore), Oliver Bechter(KU Leuven), S. Prey, Martin Kaatz(SRH Wald-Klinikum Gera), Karl D. Lewis(University of Colorado Denver), Nicole Basset‐Séguin(Hôpital Saint-Louis), Anne Lynn S. Chang(Stanford University), Stéphane Dalle(Hospices Civils de Lyon), Almudena Fernández Orland(Hospital Universitario Virgen Macarena), Lisa Licitra(University of Milan), Caroline Robert(Université Paris-Saclay), Claas Ulrich(Charité - Universitätsmedizin Berlin), Axel Hauschild(Kiel University), Michael R. Migden(The University of Texas MD Anderson Cancer Center), Reinhard Dummer(University Hospital of Zurich), Siyu Li(Regeneron (United States)), Suk-Young Yoo(Regeneron (United States)), Kosalai Kal Mohan(Regeneron (United States)), Ebony Coates(Regeneron (United States)), Vladimir Janković(Regeneron (United States)), Nathalie Fiaschi(Regeneron (United States)), Emmanuel Chiebuka Okoye(Regeneron (United States)), Ioannis D. Bassukas(University of Ioannina), Carmen Loquai(University Medical Center of the Johannes Gutenberg University Mainz), Vincenzo De Giorgi(University of Florence), Zeynep Eroglu(Moffitt Cancer Center), Ralf Gutzmer(Medizinische Hochschule Hannover), Jens Ulrich, Susana Puig(Instituto de Salud Carlos III), Frank Seebach(Regeneron (United States)), Gavin Thurston(Regeneron (United States)), David M. Weinreich(Regeneron (United States)), George D. Yancopoulos(Regeneron (United States)), Israel Lowy(Regeneron (United States)), Timothy G. Bowler(Regeneron (United States)), Matthew G. Fury(Regeneron (United States))
Cited by 275Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis